MiniMed Group (NASDAQ:MMED) Shares Break Below 200-Day Moving Average – Time to Sell?

MiniMed Group Inc (NASDAQ:MMED – Get Free Report) shares passed below its 200-day moving average during trading on Thursday. The stock has a 200-day moving average of $16.74 and traded as low as $16.14. MiniMed Group shares last traded at $16.26, with a volume of 6,972,689 shares traded.

Wall Street Analyst Weigh In

Several equities research analysts have commented on MMED shares. Morgan Stanley increased their price objective on shares of MiniMed Group from $19.00 to $21.00 and gave the company an “overweight” rating in a research note on Thursday, September 3rd. BTIG Research boosted their target price on MiniMed Group from $25.00 to $28.00 and gave the stock a “buy” rating in a research note on Tuesday, September 1st. Truist Financial assumed coverage on MiniMed Group in a report on Thursday, September 24th. They issued a “buy” rating and a $29.00 target price for the company. Citigroup increased their price target on MiniMed Group from $23.00 to $26.00 and gave the company a “buy” rating in a research report on Wednesday, September 2nd. Finally, Wells Fargo & Company lifted their price target on MiniMed Group from $22.00 to $26.00 and gave the stock an “overweight” rating in a report on Wednesday, September 2nd. Fourteen investment analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $24.12.

Check Out Our Latest Analysis on MiniMed Group

MiniMed Group Stock Performance

The company has a market cap of $4.57 billion and a PE ratio of -23.91. The business’s 50-day moving average is $19.16 and its 200 day moving average is $16.74.

Hedge Funds Weigh In On MiniMed Group

A number of hedge funds have recently bought and sold shares of the business. BlackRock Inc. boosted its holdings in MiniMed Group by 7,527.5% in the 2nd quarter. BlackRock Inc. now owns 1,996,489 shares of the company’s stock worth $29,848,000 after buying an additional 1,970,314 shares during the period. Healthcare of Ontario Pension Plan Trust Fund lifted its position in shares of MiniMed Group by 358.7% in the third quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 1,720,000 shares of the company’s stock valued at $33,488,000 after acquiring an additional 1,345,000 shares in the last quarter. Boston Partners lifted its position in shares of MiniMed Group by 0.6% in the third quarter. Boston Partners now owns 908,007 shares of the company’s stock valued at $17,695,000 after acquiring an additional 5,648 shares in the last quarter. J. Goldman & Co LP bought a new position in shares of MiniMed Group in the second quarter worth about $12,412,000. Finally, First Trust Advisors LP boosted its stake in shares of MiniMed Group by 124.7% in the third quarter. First Trust Advisors LP now owns 822,845 shares of the company’s stock worth $16,021,000 after acquiring an additional 456,577 shares during the period.

MiniMed Group Company Profile

(Get Free Report)

MiniMed Group focuses on diabetes technology, developing products and services to help people manage insulin-dependent diabetes. Its offerings include insulin pumps, continuous glucose monitoring systems, infusion sets and software for tracking glucose and coordinating insulin delivery. The business is known for automated insulin-delivery systems that use glucose readings to help adjust insulin delivery, including products in the MiniMed 780G system line. Its technologies are intended for use by people with diabetes and the clinicians who support their care.

Recommended Stories

Receive News & Ratings for MiniMed Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MiniMed Group and related companies with MarketBeat.com's FREE daily email newsletter.